Furthermore, we have revealed that this key role of JNK is not unique to glioblastoma, but is shared by other malignancies, such as ovarian, pancreatic, and possibly lung cancers, suggesting that JNK inhibitors like SP600125 could prove effective against different human cancers through the elimination of cancer stem cells [11–13]. Here, MAPK8 is linked to cancer.